Bal Pharma fundamental analysis

BALPHARMA

80.39

0.05 (0.06%)
Last updated on 14 May, 2026 | 12:32 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Bal Pharma Fundamentals

P/E Ratio

15.91

P/B Ratio

1.61

Div. Yield

1.48

Sector P/E

67.07

Sector P/B

3.49

Sec. Div. Yield

0.57

Bal Pharma Fundamentals is currently trading with a P/E Ratio of 15.91, compared to the sector average of 67.07. Its P/B Ratio stands at 1.61, while the sector’s is 3.49. In terms of returns, the stock offers a Dividend Yield of 1.48%, which is than the sector’s 0.57%.

Bal Pharma Score Card

  • price_icon
    Price

    Expensive

  • chart_icon
    Growth

    Average

  • quality_check
    Quality

    Poor

  • quality_check
    Management

    Poor

On its scorecard, Bal Pharma reflects: Price – Expensive, Growth – Average, Quality – Poor, and Management – Poor. Together, these indicators provide a structured view of the company’s fundamentals.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost